This study is an observational registry for patients experiencing cardiogenic shock (a severe condition where your heart can't pump enough blood to meet your body's needs). Researchers are collecting information from medical records and follow-up phone calls about how patients with cardiogenic shock are treated with medications like vasopressors (phenylephrine, norepinephrine, epinephrine, dopamine, vasopressin) and inotropes (dobutamine, milrinone), as well as devices like ECMO, Impella, and IABP. The goal is to understand how these treatments affect patient outcomes, specifically looking at death rates 30 days and one year after leaving the hospital. You may be eligible if you are 18 years or older and have cardiogenic shock, defined by specific heart measurements. The study aims to enroll 5000 participants, but its current status is unclear.

Study design

This is an observational study collecting de-identified clinical information from medical records and follow-up phone calls from many hospitals. It aims to include 5000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants' mortality rates will be measured at 30 days and 1 year after hospital discharge.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.